补充异常导致恶性高血压相关的血栓性微血管病的发展
Rong Lian1,2, Wenchuan Li1, Yuejiao Li1,2
1Department of Nephrology, Guangzhou First People's Hospital, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Clinical kidney journal
|August 27, 2025
概括
患有恶性高血压和血栓性微血管病的患者的补体水平异常预示着更糟糕的结局. 这突显了补充剂在疾病进展中的作用,
科学领域:
- 肝脏病学
- 免疫学
- 高血压研究
背景情况:
- 血栓小血管病 (TMA) 是恶性高血压 (mHTN) 的严重并发症.
- 补充激活是TMA的已知因素,但其在mHTN相关的TMA的预后价值尚不清楚.
研究的目的:
- 研究恶性高血压和TMA患者的补体异常的预后意义.
- 确定补充剂水平是否会影响该患者队列中的功能恢复.
主要方法:
- 一项前性队列研究,对189名mHTN和TMA患者进行样检查.
- 根据血清C3和C4水平,患者被分为正常和异常补充组.
- 考克斯回归模型分析了预后的风险因素.
主要成果:
- 在14. 8%的患者中发现异常补充水平,与较低的BMI,血红蛋白和血小板数量有关.
- 在异常补充组中,血管内红细胞碎片和C3c/ C5b-9的质沉积更为频繁.
- 异常补充水平独立预测了较差的功能恢复 (HR 0. 368, P=0. 043).
结论:
- 在mHTN相关的TMA中,异常补充水平与较差的预后有关.
- 补充异常似乎推动了mHTN相关的TMA的进展.
- 淋巴细胞硬化也仍然是不良结局的重要预测因素.
更多相关视频
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Cardiomyopathy III: Hypertrophic Cardiomyopathy
47
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Mitral Valve Prolapse I: Introduction
42
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
42
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Disorders of the Autonomic Nervous System
821
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
821


